{"id":25505,"date":"2023-01-20T07:08:36","date_gmt":"2023-01-20T12:08:36","guid":{"rendered":"https:\/\/www.ipoboutique.com\/blog\/?p=25505"},"modified":"2023-01-20T07:08:36","modified_gmt":"2023-01-20T12:08:36","slug":"pipeline-update-xiaomi-backed-hesai-group-among-new-filings-to-trickle-in","status":"publish","type":"post","link":"https:\/\/www.ipoboutique.com\/blog\/pipeline-update-xiaomi-backed-hesai-group-among-new-filings-to-trickle-in\/","title":{"rendered":"Pipeline Update: Xiaomi backed Hesai Group among new filings to trickle in"},"content":{"rendered":"<p><span style=\"text-decoration: underline;\"><strong>NEW FILINGS (also updated prospectuses)<\/strong><\/span><\/p>\n<p>&nbsp;<\/p>\n<p>Company: Mineralys Therapeutics, Inc.<br \/>\nSymbol: MLYS (Nasdaq)<br \/>\nDescription: They are a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone.<br \/>\nShares: TBD<br \/>\nPrice Range: TBD<br \/>\nTrade Date: TBD<br \/>\nUnderwriters: BofA Securities, Evercore ISI, Stifel, Guggenheim Securities, Credit Suisse, Wells Fargo<br \/>\nLink to Prospectus: <a href=\"https:\/\/www.sec.gov\/Archives\/edgar\/data\/1933414\/000162828023001171\/mineralys-sx1.htm\"><strong>Filed 1-18-23<\/strong><\/a><\/p>\n<p>Company: Hesai Group<br \/>\nSymbol: HSAI (Nasdaq)<br \/>\nDescription: Hesai Technology is the global leader in three-dimensional light detection and ranging (LiDAR) solutions.<br \/>\nShares: TBD<br \/>\nPrice Range: TBD<br \/>\nTrade Date: TBD<br \/>\nUnderwriters: Goldman Sachs, Morgan Stanley, Credit Suisse, Huatai Securities<br \/>\nLink to Prospectus: <a href=\"https:\/\/www.sec.gov\/Archives\/edgar\/data\/1861737\/000110465923004072\/tm2120356-19_f1.htm\"><strong>Filed 1-17-23<\/strong><\/a><\/p>\n<p>Company: Nextracker Inc.<br \/>\nSymbol: NXT (Nasdaq)<br \/>\nDescription: They are a leading provider of intelligent, integrated solar tracker and software solutions used in utility-scale and ground-mounted distributed generation solar projects around the world.<br \/>\nShares: TBD<br \/>\nPrice Range: TBD<br \/>\nTrade Date: TBD<br \/>\nUnderwriters: JP Morgan, BofA Securities, Citigroup, Barclays<br \/>\nCo-Manager(s): Truist Securities, HSBC, BNP PARIBAS, Mizuho, ScotiaBank, KeyBanc Capital, SMBC Nikko, BTIG, UniCredit, Roth Capital<br \/>\nLink to Prospectus: <a href=\"https:\/\/www.sec.gov\/Archives\/edgar\/data\/1852131\/000119312523008499\/d139910ds1.htm\"><strong>Filed: 1-13-23<\/strong><\/a><\/p>\n<p>Company: BKV Corporation<br \/>\nSymbol: BKV (NYSE)<br \/>\nDescription: They are a forward thinking, growth driven energy company focused on creating value for our stockholders through the organic development of our properties as well as accretive acquisitions.<br \/>\nShares: TBD<br \/>\nPrice Range: TBD<br \/>\nTrade Date: TBD<br \/>\nUnderwriters: Credit Suisse, BofA Securities, Barclays, Citigroup, Evercore ISI, Jefferies<br \/>\nCo-Manager(s): TPH &amp; Co., Susquehanna Financial Group, SMBC Nikko<br \/>\nLink to Prospectus: <a href=\"https:\/\/www.sec.gov\/Archives\/edgar\/data\/1838406\/000110465923004330\/tm2217921-18_s1a.htm\"><strong>Amended Prospectus: 01-18-23<\/strong><\/a><\/p>\n<p>&nbsp;<\/p>\n<p><span style=\"text-decoration: underline;\"><strong>TERMS ADDED<\/strong><\/span><\/p>\n<p>&nbsp;<\/p>\n<p>Company: TXO Energy Partners, L.P.<br \/>\nSymbol: TXO (NYSE)<br \/>\nDescription: They are focused on the acquisition, development, optimization and exploitation of conventional oil, natural gas, and natural gas liquid reserves in North America.<br \/>\nShares: 5 million (units)<br \/>\nPrice Range: $19.00-$21.00<br \/>\nMarket Cap: $570m-$630m<br \/>\nTrade Date: Friday, 1\/27<br \/>\nUnderwriters: Raymond James, Stifel<br \/>\nCo-Manager(s): Janney Montgomery Scott, Capital One Securities<br \/>\nLink to Prospectus: <a href=\"https:\/\/www.sec.gov\/Archives\/edgar\/data\/1559432\/000119312523009879\/d364234ds1a.htm\"><strong>Terms Added: 1-18-23<\/strong><\/a><\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>NEW FILINGS (also updated prospectuses) &nbsp; Company: Mineralys Therapeutics, Inc. Symbol: MLYS (Nasdaq) Description: They are a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. Shares: TBD Price Range: TBD Trade Date: TBD Underwriters: BofA Securities, Evercore ISI, Stifel, Guggenheim Securities, Credit Suisse, Wells Fargo Link to Prospectus:[&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":null,"zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":null,"zakra_breadcrumbs_separator_color":null,"zakra_breadcrumbs_link_color":null,"zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[1536],"tags":[],"class_list":["post-25505","post","type-post","status-publish","format-standard","hentry","category-subscriber-content"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/25505","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=25505"}],"version-history":[{"count":1,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/25505\/revisions"}],"predecessor-version":[{"id":25506,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/25505\/revisions\/25506"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=25505"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=25505"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=25505"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}